Local and Global News
Friday, February 10, 2017
Three organizations partner to establish $1.2M Alberta Transplant Innovation Fund. Through collaboration of researchers, clinicians, industry leaders, government and philanthropy, Funding research to improve care of transplant patients.
The Alberta Diabetes Institute at the University of Alberta is pleased to announce a collaboration with Janssen Pharmaceuticals and its parent company Johnson & Johnson to advance early-stage technologies related to Type I and Type II diabetes.
The Canada-Alberta Job Grant (CAJG) is a funding program where employers and government share the cost of training new and existing employees to increase their knowledge and skills to meet the needs of Alberta’s changing economy.